SLC9A1 Binding mTOR Signaling Pathway-Derived Risk Score Predicting Survival and Immune in Clear Cell Renal Cell Carcinoma

Figure 4

Construction of the prognostic risk model in TCGA cohort and ICGC cohort. (a) The trajectory of each gene coefficient with lambda. (b) 10-fold cross-validation was used to find the best values for the penalty parameter. (c) The Kaplan–Meier (K–M) survival curve showed patients in the high- and low-risk group in TCGA dataset. (d) The prognostic signature’s ROC curve at 1, 2, 3, 4, and 5 years in TCGA dataset. (e) The K–M survival curve showed that patients in the high- and low-risk group in the ICGC dataset. (f) The prognostic signature’s ROC curve at 1, 2, 3, 4, and 5 years in the ICGC dataset.

(a)

(b)

(c)

(d)

(e)

(f)